8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K

                Current Report Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934


          Date of Report (Date of earliest event reported):  September 10, 1998

                               ---------------------


                          Boston Scientific Corporation
               (Exact name of registrant as specified in charter)



       DELAWARE                      1-11083                         04-2695240
(State or other jurisdiction      (Commission                     (IRS employer
  of incorporation)               file number)               identification no.)

          One Boston Scientific Place, Natick, Massachusetts 01760-1537
           (Address of principal executive offices including zip code)

       Registrant's telephone number, including area code: (508) 650-8000











Item 5.        Other Events

            On September 10, 1998, Boston Scientific Corporation (the "Company")
announced that it had completed its acquisition of Schneider Worldwide, a member
of the Medical Technology Group of Pfizer Inc., for $2.1 billion in cash. The
purchase price was funded by the issuance of commercial paper.

            The commercial paper issued will not be and has not been registered
under the Securities Act of 1933.  Purchasers of the commercial paper may not
reoffer or resell it in the United States absent registration or an applicable
exemption from registration requirements.

Item 7.        Financial Statements, Pro Forma Financial Information and
Exhibits


               Exhibit Number      Description
               --------------      -----------

                   99.1            Press Release dated September 10, 1998











                                   SIGNATURES

               Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.


                                                  BOSTON SCIENTIFIC CORPORATION

Date:  September 10, 1998                         By:/s/ Lawrence J. Knopf
                                                     ---------------------
                                                     Lawrence J. Knopf
                                                     Vice President and
                                                     Assistant General Counsel








                                INDEX TO EXHIBITS



Exhibit                Exhibit
Number                 Description                                         Page

99.1                   Press Release dated September 10, 1998                1

EX-99.1

                                                                   EXHIBIT 99.1

                                BOSTON SCIENTIFIC
                             ANNOUNCES COMPLETION OF
                              SCHNEIDER ACQUISITION


        Natick, MA (September 10, 1998)--Boston Scientific Corporation
        (NYSE:BSX) announced today that it has completed its acquisition of
        Schneider Worldwide, a member of the Medical Technology Group of Pfizer
        Inc. (NYSE:PFE), for $2.1 billion in cash. The purchase price was
        funded by the issuance of commercial paper.

        Boston Scientific is a worldwide developer, manufacturer and marketer of
        medical devices. The Company's products are used in a broad range of
        interventional medical specialties.





                                CONTACT:       Larry Best (508-650-8450)
                                               Sabrina Nicholson (508-647-2551)
                                               Boston Scientific Corporation













         The commercial paper will not be and has not been registered under the
         Securities Act of 1933. Purchasers of the commerical paper may not
         reoffer or resell it in the United States absent registration or an
         applicable exemption from registration requirements.